Ladenburg Thalmann Financial Services’s Viking Therapeutics VKTX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$47K	Buy	5,852 +549	+10%	+$4K	﹤0.01%	3574
2019 Q3	$37K	Sell	5,303 -3,300	-38%	-$24.5K	﹤0.01%	3651
2019 Q2	$71K	Buy	8,603 +550	+7%	+$4.7K	﹤0.01%	3222
2019 Q1	$80K	Buy	8,053 +2,870	+55%	+$24K	﹤0.01%	3049
2018 Q4	$40K	Buy	5,183 +2,945	+132%	+$35.2K	﹤0.01%	3416
2018 Q3	$39K	Buy	2,238 +1,412	+171%	+$16.8K	﹤0.01%	3492
2018 Q2	$4K	Hold	826	–	–	﹤0.01%	4692
2018 Q1	$4K	Buy	+826	New	+$4.57K	﹤0.01%	4692

Other funds holding VKTX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Ladenburg Thalmann Financial Services's VKTX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Viking Therapeutics (VKTX) stake by 10% in Q4 2019, buying an estimated $4K and bringing the position to 5,852 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

Ladenburg Thalmann Financial Services first reported a position in VKTX in Q1 2018 and has held it in 8 quarters since. The position peaked at $80K in Q1 2019. 143 funds tracked by Wall St. Rank hold VKTX as of Q4 2019.

Ladenburg Thalmann Financial Services held 5,852 shares of Viking Therapeutics worth $47K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 549 Viking Therapeutics shares in Q4 2019, an estimated $4K.
Viking Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3574 holding.
Ladenburg Thalmann Financial Services first reported a position in Viking Therapeutics in Q1 2018 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's Viking Therapeutics position peaked at $80K in Q1 2019.
143 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.